NewAmsterdam Pharma Company N.V. - Rasio total nilai perusahaan marang pendapatan NAMS

newamsterdampharma.com (NAMS) - logo korporat

NewAmsterdam Pharma (NAMS) is developing advanced cardiometabolic agents, overcoming pressure from industry behemoths and the availability of cheap statins. The enterprise value-to-revenue multiple demonstrates the efficiency of the operating model, where 65928.30 reflects the latest metric value. The strategy relies on patenting unique formulas to capture a niche, promising colossal demand among millions of patients with resistant cholesterol.

NAMS NewAmsterdam Pharma: Rasio nilai perusahaan marang pendapatan ing interval 23.11.2025 - 20.11.2026

newamsterdampharma.com - rincian analitis lan metrik utama (NAMS)

- rega saham lan prakiraan rega para ahli:
Pambiji fundamental:NewAmsterdam Pharma
Produk dadi NewAmsterdam Pharma

NewAmsterdam Pharma (NAMS) is currently in the clinical trial stage for metabolic therapy, which results in a lack of stable operating income and a high-risk business model. The current value of 65928.30 reflects the ratio of enterprise value to revenue excluding debt, allowing the EV/Sales history to assess market expectations for future products and the efficiency of capitalization management amid uncertain cash flows.

Analisis pesaing NewAmsterdam Pharma

ASND: Rasio nilai perusahaan marang pendapatan|MDGL: Multiplikator EV/Sales|CORT - Rasio total nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan Rhythm Corp|Akero Corp (AKRO) - Rasio total nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan metsera.com (MTSR)|Nilai perusahaan marang pendapatan moonlaketx.com MLTX|Multiplikator EV/Sales CRNX (Crinetics Pharmaceuticals, Inc.)|Rasio total nilai perusahaan marang pendapatan Soleno Therapeutics Inc (SLNO)|FOLD - Rasio nilai perusahaan marang pendapatan|ETNB: Rasio nilai perusahaan marang pendapatan|AGIO: Multiplikator EV/Sales|Structure Therapeutics Inc. - Nilai bisnis marang pendapatan|MDXG (MiMedx Corp) - Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan Rezolute Inc RZLT|Multiplikator EV/Sales LXRX|Rasio total nilai perusahaan marang pendapatan MBX Corp|Altimmune Pharma - Nilai perusahaan marang pendapatan|Multiplikator EV/Sales aardvarktherapeutics.com AARD|SGMT: Nilai perusahaan marang pendapatan|Nilai bisnis marang pendapatan BIOA (BioAge Labs)|BMEA: Multiplikator EV/Sales|QNCX: Koefisien nilai perusahaan marang pendapatan|GUTS (Fractyl Health, Inc.) - Multiplikator EV/Sales|Multiplikator EV/Sales vtvtherapeutics.com|Nilai perusahaan marang pendapatan ATPC (Agape ATP Corp)|Rasio total nilai perusahaan marang pendapatan Pluristem Therapeutics|Rasio nilai perusahaan marang pendapatan synlogictx.com SYBX|LPCN: Rasio nilai perusahaan marang pendapatan|MTNB - Rasio nilai perusahaan marang pendapatan|Spruce Biosciences, Inc. (SPRB) - Nilai perusahaan marang pendapatan|GLTO: Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan Carmell Corp. (CTCX)|LUMO (Lumos Therapeutics) - Multiplikator EV/Sales|Organovo Corp (ONVO) - Rasio total nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan Radius Recycling (RDUS)